Get the Stockscreener App
14.40
1.37%
-0.20
After Hours:
14.40
Shoulder Innovations Inc stock is traded at $14.40, with a volume of 90,855.
It is down -1.37% in the last 24 hours and up +7.06% over the past month.
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.
See More
Previous Close:
$14.60
Open:
$14.87
24h Volume:
90,855
Relative Volume:
1.20
Market Cap:
$297.32M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-0.4806
EPS:
-29.96
Net Cash Flow:
-
1W Performance:
-5.39%
1M Performance:
+7.06%
6M Performance:
+15.20%
1Y Performance:
+1,043%
1-Day Range:
$14.30
$15.22
1-Week Range:
$13.97
$15.41
52-Week Range:
$10.92
$17.94
Shoulder Innovations Inc Stock (SI) Company Profile
Name
Shoulder Innovations Inc
Sector
Industry
Phone
616-566-0286
Address
1535 STEELE AVENUE SW, SUITE B, GRAND RAPIDS
Compare SI vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SI
Shoulder Innovations Inc
|
14.40 | 301.45M | 0 | 0 | 0 | 0.00 |
ABT
Abbott Laboratories
|
104.83 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.65 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.89 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.78 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Shoulder Innovations Inc Stock (SI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-25-25 | Initiated | BTIG Research | Buy |
| Aug-25-25 | Initiated | Goldman | Buy |
| Aug-25-25 | Initiated | Jefferies | Buy |
| Aug-25-25 | Initiated | Piper Sandler | Overweight |
| Mar-06-23 | Downgrade | Compass Point | Neutral → Sell |
| Mar-06-23 | Downgrade | Wedbush | Neutral → Underperform |
| Mar-02-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Mar-02-23 | Downgrade | Compass Point | Buy → Neutral |
| Mar-02-23 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-01-23 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Jan-09-23 | Downgrade | Wedbush | Outperform → Neutral |
| Jan-06-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-06-23 | Downgrade | Craig Hallum | Buy → Hold |
| Jan-06-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-12-22 | Reiterated | Wedbush | Outperform |
| Dec-05-22 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-21-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Nov-10-22 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-26-22 | Downgrade | Goldman | Buy → Neutral |
| Oct-06-22 | Downgrade | Wells Fargo | Overweight → Underweight |
| Aug-04-22 | Initiated | BTIG Research | Buy |
| Jun-13-22 | Initiated | Wells Fargo | Overweight |
| Jun-09-22 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-21-22 | Initiated | BofA Securities | Buy |
| Jan-20-22 | Upgrade | Goldman | Neutral → Buy |
| Dec-16-21 | Initiated | B. Riley Securities | Buy |
| Nov-11-21 | Initiated | JP Morgan | Overweight |
| Nov-08-21 | Downgrade | Keefe Bruyette | Outperform → Mkt Perform |
| Sep-27-21 | Initiated | Morgan Stanley | Overweight |
| Jun-14-21 | Initiated | Goldman | Neutral |
| Jan-14-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-22-20 | Initiated | Wedbush | Outperform |
| Dec-17-20 | Upgrade | Keefe Bruyette | Mkt Perform → Outperform |
| Dec-02-20 | Initiated | Craig Hallum | Buy |
| Oct-16-20 | Initiated | Compass Point | Buy |
| Mar-16-20 | Initiated | Canaccord Genuity | Buy |
| Dec-03-19 | Initiated | Keefe Bruyette | Mkt Perform |
| Dec-02-19 | Initiated | Barclays | Overweight |
| Nov-18-19 | Initiated | Compass Point | Buy |
View All
Shoulder Innovations Inc Stock (SI) Latest News
Shoulder Innovations (NYSE:SI) And Medline Healthcare Manufacturing Enabling Smarter Care - Kalkine Media
Critical Review: Shoulder Innovations (NYSE:SI) and Medline (NASDAQ:MDLN) - Defense World
Financial Analysis: Shoulder Innovations (NYSE:SI) and Medline (NASDAQ:MDLN) - Defense World
Top Brass Pile Into Shoulder Innovations Stock in a Bold Insider Buying Spree - TipRanks
Ball Robert Joseph, CEO, buys Shoulder Innovations (SI) shares worth $33,392 By Investing.com - Investing.com South Africa
Ball Robert Joseph, CEO, buys Shoulder Innovations (SI) shares worth $33,392 - Investing.com India
Shoulder Innovations (NYSE:SI) CEO Robert Joseph Ball Acquires 2,200 Shares - MarketBeat
Insider Buying: Shoulder Innovations (NYSE:SI) CFO Acquires 2,000 Shares of Stock - MarketBeat
Shoulder Innovations (NYSE:SI) Director Purchases $14,840.00 in Stock - MarketBeat
Buchholz Richard buys shoulder innovations (SI) stock worth $14,840 - Investing.com
Buchholz Richard buys shoulder innovations (SI) stock worth $14,840 By Investing.com - Investing.com South Africa
Shoulder Innovations (SI) CFO exercises options and buys additional shares - Stock Titan
Director exercises 45,606 options in Shoulder Innovations (SI) - Stock Titan
Director buys 1,000 Shoulder Innovations (SI) shares at $14.84 - Stock Titan
Shoulder Innovations (SI) CEO adds 2,200 shares in open-market buy - Stock Titan
SI SEC FilingsShoulder Innovations, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Shoulder Innovations, Inc. (NYSE:SI) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Shoulder Innovations (SI) Stock Forecast and Price Target 2026 $SI - MarketBeat
Analysts Have Conflicting Sentiments on These Healthcare Companies: Atricure (ATRC), Q32 Bio (QTTB) and Shoulder Innovations, Inc. (SI) - The Globe and Mail
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Evotec AG (EVO), Shoulder Innovations, Inc. (SI) and Bausch + Lomb Corporation (BLCO) - The Globe and Mail
Shoulder Innovations (SI) Revenue Growth Reinforces Bullish Narratives Despite Continued EPS Loss - simplywall.st
Shoulder Innovations, Inc. – Transforming Shoulder Surgical Care with Advanced Implant Systems and AI-Enabled Technologies (2025 Company Overview) - Minichart
Shoulder Innovations (NYSE:SI) Issues Quarterly Earnings Results, Beats Expectations By $0.04 EPS - MarketBeat
BTIG Research Issues Positive Forecast for Shoulder Innovations (NYSE:SI) Stock Price - MarketBeat
BTIG raises Shoulder Innovations stock price target on revenue beat By Investing.com - Investing.com Nigeria
Shoulder Innovations revenue up 65% to USD 14.4M in Q4 2025 - Medical Buyer
Shoulder Innovations Reports Fourth Quarter and Full Year 2025 Financial Results - The Malaysian Reserve
BTIG raises Shoulder Innovations stock price target on revenue beat - Investing.com South Africa
Earnings call transcript: Shoulder Innovations reports strong Q4 2025 growth By Investing.com - Investing.com Canada
Shoulder Innovations Q4 Earnings Call Highlights - MarketBeat
Shoulder Innovations Reports Fourth Quarter And Full Year 2025 Financial Results - TradingView
Shoulder Innovations Inc reports results for the quarter ended December 31Earnings Summary - TradingView
SI: Exceptional 2025 growth with robust 2026 outlook, fueled by innovation and ASC momentum - TradingView
Earnings call transcript: Shoulder Innovations reports strong Q4 2025 growth - Investing.com
Shoulder Innovations Reports Transformational 2025 Growth and Guidance - TipRanks
AAR to announce third quarter fiscal year 2026 results on March 24, 2026 - Weekly Voice
SHOULDER INNOVATIONS ($SI) Releases Q4 2025 Earnings - Quiver Quantitative
SI: Innovative implants and AI-driven planning fuel rapid growth and high margins in shoulder arthroplasty - TradingView
SI: Q4 revenue up 65% year-over-year; 2026 guidance targets 31–37% growth - TradingView
Shoulder Innovations (NYSE: SI) 2025 revenue jumps 50% as losses widen - Stock Titan
Shoulder Innovations Q4 2025 Earnings Call Transcript - MarketBeat
Shoulder Innovations Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView
SI Earnings History & Surprises | EPS & Revenue Results | SHOULDER INNOVATIONS INC (NYSE:SI) - ChartMill
Director Andrew Hykes files Form 3 at Shoulder Innovations (SI) - Stock Titan
Shoulder Innovations, Inc. (NYSE:SI) Short Interest Update - MarketBeat
SI: AI-driven planning, innovative implants, and robotics fuel rapid growth in shoulder arthroplasty - TradingView
Shoulder Innovations adds Drew Hykes to board of directors By Investing.com - Investing.com South Africa
Shoulder Innovations adds Drew Hykes to board of directors - Investing.com
Shoulder Innovations Appoints MedTech Veteran Drew Hykes to Boar - GuruFocus
Shoulder Innovations Adds Medtech Veteran Drew Hykes to Board - TipRanks
Medtech leader Drew Hykes joins Shoulder Innovations (NYSE: SI) board after Pardo exit - Stock Titan
Shoulder Innovations Inc Stock (SI) Financials Data
There is no financial data for Shoulder Innovations Inc (SI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):